SANGERS SEQUENCING SERVICE MARKET REPORT OVERVIEW
-
.svg)
to learn more about this report
The global sangers sequencing service market size was USD 251.4 million in 2019 and will touch USD 377.2 million by 2026, exhibiting a CAGR of 5.9% during the forecast period.
Sanger sequencing services, integral to DNA analysis, exhibit a dynamic market characterized by rising demand in genomics research, diagnostics, and personalized medicine. Key players, including industry leaders like Eurofins and Thermos Fisher, offer comprehensive solutions for DNA sequencing, driving market growth. Technological advancements, cost-effectiveness, and increasing applications in clinical settings contribute to market expansion. The sector faces competition from next-generation sequencing methods, but Sanger sequencing remains pivotal for accurate, reliable DNA analysis. With a global footprint, the market is poised for sustained growth, propelled by expanding genomics applications across diverse scientific disciplines.
COVID-19 Impact: Market Growth Restrained by Pandemic due to Supply Chain Disruptions
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The COVID-19 pandemic has significantly impacted the sangers sequencing service market growth. Disruptions in supply chains, laboratory closures, and resource reallocation for pandemic-related research have led to temporary setbacks. However, the demand for genomic analysis in understanding virus variants and vaccine development has underscored the importance of sequencing services. The industry's resilience is evident as it adapts to new challenges, accelerates digital transformation, and explores applications in tracking and managing the pandemic. Despite initial disruptions, the long-term prospects remain positive, driven by ongoing genomic research and the critical role of Sanger sequencing in various scientific endeavours beyond the pandemic.
LATEST TRENDS
"Emergence of Hybrid Sequencing Technologies in Sanger Sequencing Services"
The latest trend in the Sanger sequencing service market involves the integration of hybrid sequencing technologies. Innovations are combining the accuracy of Sanger sequencing with the throughput advantages of next-generation sequencing (NGS) methods. This hybrid approach enhances the cost-effectiveness and efficiency of genomic analysis, catering to the growing demand for high-throughput, accurate, and comprehensive sequencing solutions. As research and clinical applications increasingly require nuanced genetic insights, the adoption of hybrid sequencing technologies is positioned to reshape the landscape of Sanger sequencing services, offering a potent synergy of precision and scalability.
SANGERS SEQUENCING SERVICE MARKETSEGMENTATION
-
to learn more about this report
- By Type
Based on type the global market can be categorized into Shotgun Sequencing, Targeted Gene Sequencing, Others.
Shotgun sequencing randomly breaks DNA into fragments, sequences them, and assembles the genome, enabling efficient and comprehensive genomic analysis.
Targeted gene sequencing precisely analyzes specific genes of interest, providing focused genetic information essential for research, diagnostics, and personalized medicine.
- By Application
Based on application the global market can be categorized into Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics.
Academic and government research institutes drive scientific inquiry, innovation, and policy development, fostering advancements across diverse disciplines for societal benefit.
Pharmaceutical companies innovate, develop, and produce drugs, contributing to global healthcare through research, manufacturing, and commercialization of medical solutions.
Biotechnology companies leverage cutting-edge biology and technology to innovate in healthcare, agriculture, and industry, shaping the future of scientific advancements.
Hospitals and clinics provide essential medical services, diagnostics, and treatments, promoting public health and well-being in diverse communities.
DRIVING FACTOR
"Persistent Applications in Research and Drug Development to Boost the Market"
Sanger sequencing remains indispensable in both academic and industrial research settings, supporting studies ranging from basic genetic investigations to large-scale drug development initiatives. Its reliability and ability to sequence long DNA fragments make it a preferred choice for identifying genetic targets and validating findings obtained from high-throughput methods. As pharmaceutical and biotechnology companies intensify efforts in precision medicine and targeted therapeutics, the demand for Sanger sequencing services persists, driving market growth.
"Rising Clinical Applications and Diagnostics to Bolster Market Growth"
The increasing integration of genomics into clinical practice fuels the demand for Sanger sequencing in diagnostics and personalized medicine. Sanger sequencing's accuracy is critical for identifying disease-associated mutations, confirming genetic markers, and facilitating informed clinical decision-making. The expansion of genetic testing services and the adoption of Sanger sequencing in clinical laboratories contribute significantly to the market, as healthcare providers seek reliable genomic information for tailored patient care and disease management.
RESTRAINING FACTORS
"Technological Shift Toward Next-Generation Sequencing (NGS) to Restrain Market Growth"
A prominent restraining factor in the Sanger sequencing services market is the accelerating shift towards Next-Generation Sequencing (NGS) technologies. The advent of NGS has brought about faster, more cost-effective, and high-throughput sequencing methods, outpacing the traditionally employed Sanger sequencing in various applications. As NGS continues to gain prominence for its ability to simultaneously analyze multiple DNA fragments, the demand for Sanger sequencing services faces a challenge. While Sanger sequencing excels in accuracy, its comparatively slower and less scalable nature hinders its competitiveness in the era of rapidly advancing genomics technologies, contributing to a restraint in its market growth.
SANGERS SEQUENCING SERVICE MARKETREGIONAL INSIGHTS
-
to learn more about this report
"North America to Dominate the Market due to Presence of a Large Consumer Base"
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America and Middle East & Africa.
Historically, North America, particularly the United States, has been a key player in the genomics and sequencing services sector, given the presence of major biotechnology companies, academic research institutions, and well-established healthcare infrastructure. For the most current and region-specific information on the dominance of the Sanger sequencing services market, it's recommended to refer to recent market reports, industry analysts, and updates from reliable sources in the field. Market dynamics can change, and factors such as technological advancements, research initiatives, and healthcare investments can influence the prominence of different regions in the Sanger sequencing services market.
KEY INDUSTRY PLAYERS
"Key Industry Players Shaping the Market through Innovation and Market Expansion"
Key industry players are driving innovation and expanding the Sanger sequencing services market share. Thermo Fisher Scientific, a life sciences giant, pioneers advancements in genomics through its diverse range of products and services, including cutting-edge Sanger sequencing solutions. Eurofins Scientific, a global bioanalytical testing leader, contributes significantly to genomics research by providing comprehensive Sanger sequencing services. Illumina, renowned for next-generation sequencing, also plays a role in shaping genomics with offerings that include Sanger sequencing solutions. Genewiz and Source BioScience, specializing in genomics services, focus on quality and efficiency, contributing to market growth.
List of Market Players Profiled
- Source BioScience (U.K.)
- GenScript Biotech (China)
- Thermo Fisher Scientific (U.S.)
- LGC Science Group (U.K.)
- Fasteris CeMIA (Switzerland)
- Quintara Biosciences (U.S.)
- GenHunter (U.S.)
- GENEWIZ (U.S.)
- LGC Science Group (U.K.)
- Fasteris (Switzerland)
- Microsynth (Switzerland)
INDUSTRIAL DEVELOPMENT
January 2022: Sanger Sequencing Service market has witnessed robust industrial development, driven by advancements in genomics research and personalized medicine. The demand for high-quality DNA sequencing services has surged, fostering competition among service providers. Innovations in sequencing technologies, automation, and bioinformatics have enhanced efficiency and reduced costs. Additionally, collaborations with pharmaceutical and biotech companies for large-scale genomic projects have further fueled market growth. As a result, the Sanger Sequencing Service market is characterized by dynamic expansion, with a focus on delivering accurate and cost-effective sequencing solutions to meet the evolving needs of diverse industries, including healthcare, agriculture, and environmental research.
REPORT COVERAGE
The Sanger Sequencing Service market has experienced substantial growth, propelled by technological advancements and increasing applications across various industries. The competitive landscape has intensified, with a heightened focus on precision, efficiency, and cost-effectiveness. Collaborations with key sectors such as healthcare and agriculture underscore the market's pivotal role in advancing scientific research. As the demand for reliable DNA sequencing continues to rise, the market is poised for sustained expansion, offering diverse industries invaluable tools for genomic exploration. The future holds promising prospects, marked by ongoing innovations and strategic partnerships that will further shape the landscape of Sanger Sequencing Services.
| REPORT COVERAGE | DETAILS |
|---|---|
Market Size Value In |
US$ 251.4 Million in 2019 |
Market Size Value By |
US$ 377.2 Million by 2026 |
Growth Rate |
CAGR of 5.6% from 2019 to 2026 |
Forecast Period |
2022-2026 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is Sangers Sequencing Service market expected to touch by 2026?
The Sangers Sequencing Service market is expected to reach USD 377.2 million by 2026.
-
What CAGR is the Sangers Sequencing Service market expected to exhibit by 2026?
The Sangers Sequencing Service market is expected to exhibit a CAGR of 5.6% by 2026.
-
Which are the driving factors of the Sangers Sequencing Service market?
Genomic research demand, precision medicine applications, and advancements in DNA analysis propel the Sanger sequencing service market growth.
-
What are the Sangers Sequencing Service market segments?
The Sangers Sequencing Service market segmentation that you should be aware of, which include, Based on type into Shotgun Sequencing, Targeted Gene Sequencing, Others. Based on application Academic and Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals and Clinics.
